Insider Shareholders with Direct Ownership of Iovance Biotherapeutics, Inc. (IOVA)
This section provides a comprehensive overview of the insiders with direct ownership of Iovance Biotherapeutics, Inc. (IOVA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
IOVANCE BIOTHERAPEUTICS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Merrill A Mcpeak
Director |
310,000 | 0 | 320,150 $2.4 Million | 4 |
Feb 20, 2024
Added 43.85%
|
|
Frederick G Vogt
Interim CEO & General Counsel |
350,953 | 140,717 | 210,236 $1.57 Million | 26 |
Dec 02, 2024
Reduced 2.06%
|
|
Raj K. Puri
Chief Regulatory Officer |
8,334 | 3,759 | 155,412 $1.16 Million | 2 |
Dec 16, 2024
Reduced 2.36%
|
|
Michael Weiser
Director |
10,000 | 0 | 112,632 $843,613 | 1 |
May 31, 2022
Added 6.49%
|
|
Finckenstein Friedrich Graf
Chief Medical Officer |
121,097 | 58,446 | 62,651 $469,255 | 28 |
Dec 02, 2024
Reduced 3.07%
|
|
Igor Bilinsky
Chief Operating Officer |
116,684 | 59,145 | 57,539 $430,967 | 28 |
Dec 02, 2024
Reduced 3.01%
|
|
Iain D. Dukes
Director |
42,000 | 0 | 54,000 $404,460 | 2 |
Feb 20, 2024
Added 37.21%
|
|
Jean Marc Bellemin
Chief Financial Officer |
61,138 | 31,790 | 29,348 $219,816 | 6 |
Sep 03, 2024
Reduced 28.83%
|
|
Ryan D Maynard
Director |
57,500 | 50,000 | 7,500 $56,175 | 3 |
Nov 12, 2024
Reduced 86.96%
|